Nutex Health Inc. (NUTX): Cost of Revenue
Older than the company's other figures. The latest Cost of Revenue is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$14.65M
Year ended 2021-12-31
+206.7%
3-year compound annual growth
+34.3%
10-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2021-12-31 | $14.65M | n/m | 2022-03-31, From 2021-01-01 |
| 2020-12-31 | $909.8K | +9.6% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $830.4K | +63.6% | 2021-04-05, From 2019-01-01 |
| 2018-12-31 | $507.6K | n/m | 2020-05-14, From 2018-01-01 |
| 2017-12-31 | $30.5K | n/a | 2019-04-17, From 2017-01-01 |
| 2016-12-31 | $0 | -100.0% | 2018-04-17, From 2016-01-01 |
| 2015-12-31 | $8.1K | -98.3% | 2016-04-14, From 2015-01-01 |
| 2014-12-31 | $465.3K | -6.2% | 2015-04-15, From 2014-01-01 |
| 2013-12-31 | $496.0K | -36.7% | 2015-04-15, From 2013-01-01 |
| 2012-12-31 | $783.5K | +2.5% | 2014-04-01, From 2012-01-01 |
| 2011-12-31 | $764.7K | +95.3% | 2013-06-20, From 2011-01-01 |
| 2010-12-31 | $391.6K | n/a | 2012-03-30, From 2010-01-01 |